Lana McClements
Lana McClements
Senior Lecturer in Biotechnology
Adresă de e-mail confirmată pe uts.edu.au - Pagina de pornire
Citat de
Citat de
Mechanisms of key innate immune cells in early-and late-onset preeclampsia
I Aneman, D Pienaar, S Suvakov, TP Simic, VD Garovic, L McClements
Frontiers in immunology 11, 1864, 2020
Risk of pre‐eclampsia in women taking metformin: a systematic review and meta‐analysis
A Alqudah, MC McKinley, R McNally, U Graham, CJ Watson, TJ Lyons, ...
Diabetic Medicine 35 (2), 160-172, 2018
Top notch targeting strategies in cancer: a detailed overview of recent insights and current perspectives
G Moore, S Annett, L McClements, T Robson
Cells 9 (6), 1503, 2020
3D Bioprinted cancer models: Revolutionizing personalized cancer therapy
R Augustine, SN Kalva, R Ahmad, AA Zahid, S Hasan, A Nayeem, ...
Translational Oncology 14 (4), 101015, 2021
Targeting Treatment-Resistant Breast Cancer Stem Cells with FKBPL and Its Peptide Derivative, AD-01, via the CD44 PathwayFKBPL/AD-01 Target Breast Cancer Stem Cells
L McClements, A Yakkundi, A Papaspyropoulos, H Harrison, MP Ablett, ...
Clinical cancer research 19 (14), 3881-3893, 2013
Can stem cells beat COVID-19: advancing stem cells and extracellular vesicles toward mainstream medicine for lung injuries associated with SARS-CoV-2 infections
W Chrzanowski, SY Kim, L McClements
Frontiers in Bioengineering and Biotechnology, 554, 2020
RALA-mediated delivery of FKBPL nucleic acid therapeutics
R Bennett, A Yakkundi, HD McKeen, L McClements, TJ McKeogh, ...
Nanomedicine 10 (19), 2989-3001, 2015
Elucidating the pathogenesis of pre-eclampsia using in vitro models of spiral uterine artery remodelling
R McNally, A Alqudah, D Obradovic, L McClements
Current Hypertension Reports 19, 1-13, 2017
FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4
L McClements, S Annett, A Yakkundi, M O’Rourke, A Valentine, ...
BMC cancer 19, 1-14, 2019
Identification of RBCK1 as a novel regulator of FKBPL: implications for tumor growth and response to tamoxifen
C Donley, K McClelland, HD McKeen, L Nelson, A Yakkundi, PV Jithesh, ...
Oncogene 33 (26), 3441-3450, 2014
Hypercapnic acidosis induces mitochondrial dysfunction and impairs the ability of mesenchymal stem cells to promote distal lung epithelial repair
N Fergie, N Todd, L McClements, D McAuley, C O’Kane, ...
The FASEB Journal 33 (4), 5585, 2019
Association of Nrf2, SOD2 and GPX1 Polymorphisms with Biomarkers of Oxidative Distress and Survival in End-Stage Renal Disease Patients
D Jerotic, M Matic, S Suvakov, K Vucicevic, T Damjanovic, ...
Toxins 11 (7), 431, 2019
FKBPL is a critical antiangiogenic regulator of developmental and pathological angiogenesis
A Yakkundi, R Bennett, I Hernández-Negrete, JM Delalande, M Hanna, ...
Arteriosclerosis, thrombosis, and vascular biology 35 (4), 845-854, 2015
The anti-migratory effects of FKBPL and its peptide derivative, AD-01: regulation of CD44 and the cytoskeletal pathway
A Yakkundi, L McCallum, A O’Kane, H Dyer, J Worthington, HD McKeen, ...
PloS one 8 (2), e55075, 2013
FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancer
S Annett, G Moore, A Short, A Marshall, C McCrudden, A Yakkundi, S Das, ...
British Journal of Cancer 122 (3), 361-371, 2020
Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin–angiotensin-aldosterone system (RAAS) dysregulation
R Augustine, S Abhilash, A Nayeem, SA Salam, P Augustine, P Dan, ...
Chemico-biological interactions 351, 109738, 2022
Emerging therapeutic potential of mesenchymal stem/stromal cells in preeclampsia
S Suvakov, C Richards, V Nikolic, T Simic, K McGrath, ...
Current hypertension reports 22, 1-13, 2020
Stem cell-based approaches in cardiac tissue engineering: Controlling the microenvironment for autologous cells
R Augustine, P Dan, A Hasan, IM Khalaf, P Prasad, K Ghosal, C Gentile, ...
Biomedicine & Pharmacotherapy 138, 111425, 2021
Markers of oxidative stress and endothelial dysfunction predict haemodialysis patients survival
S Suvakov, D Jerotic, T Damjanovic, N Milic, T Pekmezovic, T Djukic, ...
American Journal of Nephrology 50 (2), 115-125, 2019
Extracellular vesicles from mesenchymal stromal cells for the treatment of inflammation-related conditions
ST Ryan, E Hosseini-Beheshti, D Afrose, X Ding, B Xia, GE Grau, CB Little, ...
International Journal of Molecular Sciences 22 (6), 3023, 2021
Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.
Articole 1–20